NCT02235402View on ClinicalTrials.gov

A Randomised, Parallel-group, Double-blind, Double-dummy Study to Compare the Effects of Lacidipine Versus Bendrofluazide on Markers of Platelet Activation and Haemorheological Factors in Hypertensive Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

December 31, 1997

Primary Completion Date

March 31, 2000

Conditions
Hypertension
Interventions
DRUG

Lacidipine

DRUG

Bendrofluazide

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02235402 - A Randomised, Parallel-group, Double-blind, Double-dummy Study to Compare the Effects of Lacidipine Versus Bendrofluazide on Markers of Platelet Activation and Haemorheological Factors in Hypertensive Patients | Biotech Hunter | Biotech Hunter